WESTLAKE CHEMICAL PARTNERS LP financials
$21.43−0.56%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Fiscal year | FY25 Dec 31 | FY24 Dec 31 | FY23 Dec 31 | FY22 Dec 31 | FY21 Dec 31 | FY20 Dec 31 | FY19 Dec 31 | FY18 Dec 31 | FY17 Dec 31 | FY16 Dec 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.17B | $1.14B | $1.19B | $1.59B | $1.21B | $966.7M | $1.09B | $1.29B | $1.17B | $986.7M |
| Gross profit | $347.8M | $418.9M | $387.5M | $377.4M | $441.7M | $378.9M | $379.4M | $377.2M | $403.7M | $391.3M |
| Gross margin | 29.8% | 36.9% | 32.5% | 23.7% | 36.4% | 39.2% | 34.8% | 29.3% | 34.4% | 39.7% |
| Operating income | $319.6M | $390.4M | $357.7M | $347.7M | $410.7M | $353.0M | $350.1M | $349.6M | $374.4M | $366.4M |
| Net income | $48.7M | $62.4M | $54.3M | $64.2M | $82.5M | $66.2M | $61.0M | $48.6M | $38.0M | $21.6M |
| Net margin | 4.2% | 5.5% | 4.6% | 4.0% | 6.8% | 6.8% | 5.6% | 3.8% | 3.2% | 2.2% |
| Diluted EPS | $1.38 | $1.77 | $1.54 | $1.82 | $2.34 | $1.88 | $1.77 | $1.51 | $1.72 | $1.50 |
| EBITDA | $447.6M | $502.3M | $467.9M | $468.8M | $519.5M | $456.1M | $457.5M | $458.4M | $488.4M | $464.7M |
| Operating cash flow | $280.5M | $485.0M | $452.0M | $463.7M | $408.4M | $373.4M | $450.8M | $436.2M | $537.4M | $287.7M |
| Free cash flow | $201.7M | $436.0M | $405.2M | $409.6M | $327.3M | $336.4M | $407.1M | $396.3M | $468.5M | -$11.9M |
| Diluted shares | 35.2M | 35.2M | 35.2M | 35.2M | 35.2M | 35.2M | 34.5M | 32.2M | 22.1M | 14.4M |
Balance sheet
| Period end | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $44.3M | $58.3M | $58.6M | $64.8M | $17.1M | $17.2M |
| Short-term investments | $0.00 | $0.00 | $0.00 | $0.00 | — | — |
| Total debt | $399.7M | $399.7M | $0.00 | $399.7M | $0.00 | $0.00 |
| Total assets | $1.26B | $1.29B | $1.32B | $1.37B | $1.48B | $1.36B |
| Total liabilities | $454.2M | $458.6M | $460.6M | $468.3M | $508.0M | $441.4M |
| Shareholders' equity | $802.4M | $829.3M | $856.3M | $903.7M | $972.7M | $915.1M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology